A new approach for personalizing treatments is currently in clinical trials : clinicians test potential therapies directly on patient-derived cells grown as 3D spheroids in the lab. Okomera has developed a device for automating and miniaturizing ex vivo cancer testing in 3D, on a single microfluidic chip. Our technology allows for multiplexing >30 conditions on a single chip. Also co-cultures and/or T-cell interactions can be tested. Installation of Okomera’s automated liquid handler at Institut Pasteur. (January 2022).
This company is:
Keywords
Industries
Where is Okomera located?
The company Okomera is located in Paris, Ile-de-France, France. It's worth noting that the company may has more corporate locations
How many employees does Okomera approximately have?
As of the latest available information Okomera has around 1-10 employees worldwide.
When was Okomera founded?
Okomera was founded in 2020
In which industries does Okomera mainly work?
The company Okomera has it's main focus in the industries of Biotechnology
What is the current company status of Okomera?
Based on the founding year and the amount of employees the company Okomera seems to be a Startup at the current state. Note that over time that status can change
Cellaria
United States
1-10 Employees
2013
ChemoSen3D Inc.
United States
1-10 Employees
2018
Carcinotech Ltd
United Kingdom
1-10 Employees
2018
CELLphenomics GmbH
Germany
1-10 Employees
2014
MiCareo Inc.
Taiwan
11-50 Employees
Molecular Devices
United States
501-1000 Employees
1983
Scixel
Spain
1-10 Employees
2012
Cherry Biotech
France
11-50 Employees
2014
Topics which have been searched by others and may be interesting for you:
